
蛋白酪氨酸磷酸酶SHP-1在细胞信号系统中的负调控作用 - 丁香园
SHP-1 作为 PTP 中重要的一员,是改变胞内磷酸化水平的关键因子,当外源性信号分子同胞膜上受体结合后激发受体分子二聚化,与受体耦联的两面神激酶(JAK)互相靠拢,通过彼此的酪氨酸磷酸化而活化,活化后 JAK 催化受体自身的酪氨酸磷酸化,形成了 SHP-1 的停泊位点。 SHP-1 与受体上的停泊位点结合而被激活,催化 JAK 的酪氨酸去磷酸化,降低激酶催化活性,进而终止信号传导。 但具体而言, SHP-1 其在不同的细胞中可产生不尽相同的胞内信号,本文从以下各种 …
中山大学蒋琳加Trends in Cell Biology综述丨SHP1和SHP2双靶向策 …
Dec 2, 2024 · SHP1和SHP2是非受体蛋白酪氨酸磷酸酶(nonreceptor protein tyrosine phosphatase)家族蛋白成员,对造血和免疫系统的正常发育和功能调节至关重要,同时在肿瘤、淋巴瘤和白血病等疾病中频繁出现突变或者表达水平降低。 文章回顾了SHP1和SHP2在造血、免疫系统发育和功能调控方面的作用,重点讨论了抑制SHP1和SHP2减少肿瘤发生、化疗耐药,同时促进免疫监视,从而双管齐下地增强抗肿瘤的治疗效果。 有兴趣在 Trends in Cell Biology 发 …
SHP-1 inhibition targets leukaemia stem cells to restore ... - Nature
Feb 6, 2024 · Here we demonstrate that inhibition of tyrosine phosphatase SHP-1 in LSCs increases their glycolysis and oxidative phosphorylation, enhancing their sensitivity to chemotherapy and vulnerability...
SHP-1: the next checkpoint target for cancer immunotherapy?
SHP-1 [protein tyrosine phosphatase, non-receptor type 6 (PTPN6)] is expressed by all mature haematopoietic lineages and at low levels, in a different isoform, by endothelial cells . There is 95% homology between human and mouse SHP-1, …
SHP-1: the next checkpoint target for cancer immunotherapy?
Apr 15, 2016 · This review will discuss the potential value of SHP-1 inhibition in future tumour immunotherapy. Keywords: SHP-1; adoptive cell transfer; checkpoint inhibitors; protein tyrosine phosphatase inhibition; tumour immunotherapy.
SHP-1 and SHP-2 in T cells: two phosphatases functioning at …
SHP-1 or PTPN6 (previously also referred to as SH-PTP1, PTP1C, HCP, or Hcph) is expressed predominantly in hematopoietic cells of all lineages and all stages of maturation, while it is expressed at low levels in epithelial cells (21, 26–28, 31).
Mechanism study of tyrosine phosphatase shp-1 in inhibiting ...
Apr 21, 2024 · Detailed studies have shown that SHP-1 regulates SHP2 expression, and SHP-1 and SHP2 are involved in macrophage M2 polarisation. SHP-1 inhibits HOXA10 and TGFβ2 which in turn regulates the...
The function of the protein tyrosine phosphatase SHP-1 in cancer
Mar 13, 2003 · SHP-1, an SH2 domain-containing protein tyrosine phosphatase, is primarily expressed in hematopoietic cells and behaves as a key regulator controlling intracellular phosphotyrosine levels in lymphocytes.
SHP-1 localization to the activating immune synapse promotes …
Apr 11, 2023 · During education, inhibitory receptors sequestered SHP-1, suggesting a model in which SHP-1 is prevented from accumulating at activating immune synapses between NK cells and their targets, thus facilitating target cell killing.
SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC ...
Aug 15, 2018 · Src homology region 2 (SH2) domain-containing phosphatase 1 (SHP-1, also known as PTPN6) is a nonreceptor protein tyrosine phosphatase that acts as a negative regulator of inflammation. Emerging evidence indicates that SHP-1 plays a role in inhibiting the progression of hepatocellular carcinoma (HCC …
- Some results have been removed